Trial Profile
Phase II randomised, double-blind, multicentre, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of 3 strengths of AD 452 in adults with active RA [rheumatoid arthritis] who are currently taking methotrexate
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs AD 452 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Sosei
- 23 Nov 2006 Status change
- 15 Nov 2006 Status change
- 21 Oct 2005 New trial record.